title: A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC).
authors.forename: W M
authors.initials: WM
authors.lastname: Tai
authors.forename: W P
authors.initials: WP
authors.lastname: Yong
authors.forename: C
authors.initials: C
authors.lastname: Lim
authors.forename: L S
authors.initials: LS
authors.lastname: Low
authors.forename: C K
authors.initials: CK
authors.lastname: Tham
authors.forename: T S
authors.initials: TS
authors.lastname: Koh
authors.forename: Q S
authors.initials: QS
authors.lastname: Ng
authors.forename: W W
authors.initials: WW
authors.lastname: Wang
authors.forename: L Z
authors.initials: LZ
authors.lastname: Wang
authors.forename: S
authors.initials: S
authors.lastname: Hartono
authors.forename: C H
authors.initials: CH
authors.lastname: Thng
authors.forename: H
authors.initials: H
authors.lastname: Huynh
authors.forename: K T
authors.initials: KT
authors.lastname: Lim
authors.forename: H C
authors.initials: HC
authors.lastname: Toh
authors.forename: B C
authors.initials: BC
authors.lastname: Goh
authors.forename: S P
authors.initials: SP
authors.lastname: Choo